ClearPoint Neuro Inc. (CLPT)

Overview

ClearPoint Neuro, Inc. is a prominent medical device company primarily operating in the United States, with a focus on developing and commercializing innovative platforms designed for performing minimally invasive surgical procedures in the brain. These procedures are guided by magnetic resonance imaging (MRI), ensuring precision and safety. The company, originally known as MRI Interventions, Inc., underwent a name change to ClearPoint Neuro, Inc. in February 2020, marking a new chapter in its commitment to advancing neurological interventions. Incorporated in 1998 and based in Solana Beach, California, ClearPoint Neuro has established various strategic license and collaboration agreements with notable entities such as Clinical Laserthermia Systems AB, Koninklijke Philips N.V., UCB Biopharma SRL, and the University of California and San Francisco. Additionally, it has entered into a development and license agreement with NE Scientific, LLC, further expanding its research and development capabilities in pursuit of innovative neurological treatment options.

Products and Services

The ClearPoint Neuro, Inc. portfolio includes the ClearPoint system, among other pioneering technologies focused on enhancing the efficacy and safety of neurosurgical interventions:

• ClearPoint System: This integrated system represents a significant advancement in the field of neurosurgery. It is specifically designed for the precise insertion of deep brain stimulation electrodes, biopsy needles, laser catheters, and the infusion of pharmaceuticals directly into the brain. The ClearPoint system facilitates these procedures under real-time MRI guidance, enabling surgeons to perform interventions with improved accuracy and reduced risk to the patient. This system underscores ClearPoint Neuro's commitment to improving the quality of life for patients undergoing neurological treatments by providing a minimally invasive alternative to traditional surgical approaches.